| | | | | |
CCCC C4 Therapeutics, Inc. | $3.8000 | -3.06% | $433.42M | $3.02M | |
HPI John Hancock Preferred Income Fund | $16.2100 | +0.37% | $432.69M | $49.13K | |
CBIO Crescent Biopharma, Inc. Common Stock | $15.2000 | -3.12% | $432.64M | $76.91K | |
| $41.7600 | +1.02% | $432.36M | $13.50K | |
DBCA D. Boral Acquisition I Corp. Class A Ordinary Shares | $10.0050 | +0.15% | $432.28M | $53.70K | |
| $8.3600 | -0.24% | $432.06M | $97.91K | |
ALTO Alto Ingredients, Inc. Common Stock | $5.6300 | -4.09% | $430.82M | $2.44M | |
KRAQ KRAKacquisition Corp Class A Ordinary Shares | $10.0000 | -0.20% | $430.81M | $2.73K | |
MESH Meshflow Acquisition Corp. Class A Ordinary Shares | $10.0000 | -0.20% | $430.81M | $32.04K | |
| $20.4000 | +0.44% | $429.72M | $318.70K | |
EOLS Evolus, Inc. Common Stock | $6.2800 | -3.68% | $429.37M | $563.24K | |
HNST The Honest Company, Inc. Common Stock | $3.9600 | +1.54% | $429.30M | $802.62K | |
CNCK Coincheck Group N.V. Ordinary Shares | $2.8900 | +7.84% | $429.00M | $56.89K | |
AUTL Autolus Therapeutics plc American Depositary Share | $1.4500 | -2.03% | $428.49M | $1.41M | |
FBRX Forte Biosciences, Inc. Common Stock | $43.2800 | -1.90% | $428.41M | $673.50K | |
